VANCOUVER, BC Sep 6, 2023 – PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA), is pleased to announce that it has qualified for trading on the OTCQB Venture Market (the “OTCQB”) in the United States operated by the OTC Markets Group Inc. and the Company’s common shares commenced trading today on the OTCQB under the symbol “PMBHF”. PharmAla’s common shares will continue to trade on the Canadian Securities Exchange (“CSE”) under the ticker “MDMA”.

“This listing is the result of an exceedingly long process, which I’m pleased we’ve finally completed,” stated Nick Kadysh, CEO, PharmAla Biotech. “We believe that this move will open the doors to greater access and trading capability in our shares for both institutional and retail investors; This is just one part of our continued efforts to grow the PharmAla story.”

PharmAla’s OTC listing, which will allow for greater access to its stock for US investors, follows the company’s receipt earlier this year of regulatory allowances from the US Food and Drug Administration (“USFDA”) for its LaNeo MDMA to be used in US Clinical Trials. The OTCQB offers investors transparent trading in entrepreneurial and development stage U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. Investors can find real-time level 2 quotes and market information at: https://www.otcmarkets.com/sto…

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up for Our Newsletter

Get the latest investment ideas and strategies sent straight to your inbox.

You May Also Like

Infinity Stone Closes Final Tranche of Private Placement

Vancouver, British Columbia–(Newsfile Corp. – October 28, 2022) – Infinity Stone Ventures…

Graphite One Comments on Energy and Critical Mineral Executive Orders Issued by President Donald Trump

Day 1 Executive Orders Include Focus on Encouraging Domestic Critical Mineral Production…

Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis

Toronto, Ontario–(Newsfile Corp. – November 1, 2023) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)…

Labrador Uranium Announces Name Change to Latitude Uranium Inc.

TORONTO, June 27, 2023 (GLOBE NEWSWIRE) — Latitude Uranium Inc. (“Latitude Uranium”, “LUR” or the “Company”) (CSE:…